Join us for an insightful seminar on the Hyperion XTi™ Imaging System and its pivotal role in advancing spatial biology. This emerging field is transforming our understanding of tissue organization in health and disease, with implications for predicting immune and therapeutic responses, improving drug development strategies, and potentially preventing or curing diseases.
While conventional microscopy techniques use fluorescence to visualize protein or RNA targets in tissue samples, they face challenges due to spectral overlap and tissue autofluorescence. The Hyperion™ XTi overcomes these limitations by utilizing Imaging Mass Cytometry™ (IMC™), a fluorescence-free approach enabling detection of 40+ targets.
IMC has expanded its capabilities with new whole slide imaging modes, which include Preview Mode, Cell Mode and Tissue Mode. These modes facilitate rapid and detailed analysis, supporting automated, continuous imaging of more than 40 large tissue samples (400 mm²) weekly. This significantly accelerates researchers’ ability to gain insights from complex biological samples.
Phenoplex™ software from Visiopharm® complements this hardware by offering a comprehensive workflow for data analysis, including automated ROI selection, phenotyping and spatial analyses of IMC images. This seminar will demonstrate how the multi-modal features of Hyperion XTi, combined with advanced analysis tools from Visiopharm, are revolutionizing our approach to spatial biology and opening new avenues for biological assessment.
James Pemberton, PhD
James holds a PhD in medical biophysics from the University of Toronto, specializing in advanced fluorescence microscopy techniques, cell biology and cell signaling mechanisms. At Standard BioTools, he currently works within product management and collaborates with R&D teams to leverage the multi-plex capabilities of the Hyperion XTi Imaging System. His goal is to drive innovation in spatial biology, enhancing our understanding of complex cellular interactions and tissue architecture in both health and disease.
